Skip to content
Bell J, Kimber J, Lintzeris N, White J, Monheit B
Australian Government Department of Health and Ageing
These clinical guidelines have been prepared to aid medical practitioners in the selection and management of patients seeking treatment with naltrexone hydrochloride for management of opioid dependence and to assist medical practitioners to provide patients with accurate information concerning naltrexone.
These clinical guidelines cover the use of naltrexone in the management of opioid dependence - in both relapse prevention and in withdrawal. The approach taken in developing these guidelines was to review published evidence, paying most weight to appropriately controlled trials. Strong research evidence is not available on many issues, and clinical consensus from a panel of experienced clinicians has been employed in developing these guidelines.
Please note these guidelines have been replaced by the National guidelines for medication-assisted treatment of opioid dependence (2014)
Bell J, Kimber J, Lintzeris N, White J, Monheit B, et al. abstract